Autogenous Vaccines Market Trends and Segments Forecast To 2028
The global autogenous vaccines market size was valued at USD 121.4 million in 2021 and is poised to grow at a CAGR of 5.8% during the forecast period 2022-2028. The primary factors that drive the market are an increase in rare communicable illnesses in companion and livestock animals, increased funding in animal care and veterinary research and development, and an increase in antimicrobial drug resistance.
View the detailed report
description here - https://precisionbusinessinsights.com/market-reports/autogenous-vaccines-market/
The global autogenous vaccines market segmentation:
1)
By Strain Type: Bacterial Strain and Virus Strain.
2)
End Users: Veterinary Clinics, Veterinary Hospitals, Veterinary Research
Institutes, and Others
Bacterial
Strain to
Dominate the Autogenous Vaccines Market
Based on strain type, bacterial strain holds the
highest market share. The major factor for the rise of this segment is because
it has greater effectiveness as compared to viral strains Staphylococcus, Salmonella, Mycoplasma,
and Haemophilus are some of the frequently used bacterial strains to produce
autogenous bacterial vaccines. Rising incidence of bacterial infections amongst
animals, fondness toward autogenous vaccines as compared to antibiotics, and
growing support and funding for international animal disease annihilation can
drive the global autogenous
vaccines market growth.
Europe
Autogenous
Vaccines Market
Europe
leads the global autogenous
vaccines market growth due to better accessibility of the product
throughout the region, and lenient regulatory scenario. Europe leads the global
market due to entrenched research infrastructure, increasing funding from
public and private sectors, and rising collaborations among global key players
have contributed to increasing the sales of autogenous vaccines in this region.
Apart from this, the major factor that drives the market in this region is rising
awareness concerning animal health among livestock animal breeders and poultry
farmers.
Strategic New Product Launches, Mergers,
Acquisitions, and Agreements are the key strategies adopted by market players
The global
Autogenous Vaccines market further reveals that the key players are
implementing strategies such as the extension of product collection through
research and development activities, product launches, acquisitions, mergers,
and strategic alliances to improve their market position and strengthen the market
revenue share.
Request sample
report at https://precisionbusinessinsights.com/request-sample/?product_id=61311
Key
players’ profiles in the autogenous vaccines market report are Serum Institute of India Pvt. Ltd.
(India), Emergent BioSolutions, Inc. (US), Biological E Limited (India), Merck
& Co., Inc. (US), Sanofi SA (France), CSL Limited (Australia), AstraZeneca
plc (UK), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation
(Japan), Pfizer, Inc. (US), Daiichi Sankyo Company, Limited (Japan), Panacea
Biotec, Ltd. (India), Johnson & Johnson (US), GlaxoSmithKline plc (UK), and
Bharat Biotech Ltd. (India)
About
Precision Business Insights:
We are a market research company that strives to
provide the highest quality market research insights. Our diverse market research
experts are enthusiastic about market research and therefore produce
high-quality research reports. We have over 500 clients with whom we have a
good business partnership and capacity to provide in-depth research analysis
for more than 30 countries. In addition to deliver more than 150 custom
solutions, we already have accounts with the top five medical device
manufacturers.
Precision Business Insights offers a variety of
cost-effective and customized research services to meet particular research requirements.
We are a leading research service provider because of our extensive database
built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll
Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/
| D U N S® Number: 85278174
Comments
Post a Comment